Biomarkers and prediction models

Saturday

May 13

16:45 - 17:45

Plenary Hall

Palliation - Oligometastases

Co-Chair: , Poland;

Chair: , United Kingdom

Overview: Proffered Papers are presented in one of the sessions scheduled in the main session halls. Each author will present orally for 7 minutes, followed by 3 minutes for discussion. Sessions will be recorded and available on-demand.

Session Code: 1500

Session Type: Proffered Papers

Track: Clinical

16:55 - 17:05

Radiotherapy 3 vs 6 Gy in Gonarthrosis and Coxarthrosis. A non-inferiority Trial.

Daniel Rivas, Spain

Presentation Number: OC-0266

17:05 - 17:15

Long-term results of an SBRT dose-escalation trial for bone and lymph node metastases (NCT03486431)

Carole Mercier, Belgium

Presentation Number: OC-0267

17:15 - 17:25

Should OARs be prioritized in SABR for oligometastases? A secondary analysis of the SABR-5 trial

Reno Eufemon Cereno, Canada

Presentation Number: OC-0268

17:25 - 17:35

Early toxicity of SBRT for oligometastatic cancer patients in the EORTC/ESTRO OligoCare cohort

, Italy

Presentation Number: OC-0269

17:35 - 17:35

Metastases-directed SRT and systemic therapy: EORTC-ESTRO OligoCare delphi consensus recommendations

, Switzerland

Presentation Number: OC-0270

17:35 - 17:45

SBRT for spine metastases: A systematic review for preparation of an ESTRO practice guideline

Ricarda Stella Guninski, Switzerland

Presentation Number: OC-0271

ESTRO 2023

Session